Nav: Home

New model developed to study inflammatory bowel disease in human biopsy samples

November 02, 2016

WASHINGTON, D.C., November 2, 2016 -- Inflammatory bowel disease (IBD) is a complex condition that requires a lifetime of care and increases a person's cancer risk. But its origins are still a mystery. Now, a team of researchers have created a new culture model of the human intestine where living tissue from a patient biopsy can be preserved and studied for days.

The model, described in a study published this week in Biomicrofluidics, from AIP Publishing, will enable researchers to study potential disease causes and test new drugs to treat IBD, said study author Amy Dawson, a postdoctoral researcher in the lab of John Greenman at the University of Hull, U.K. The study was performed in collaboration with Morten Jacobsen at the University of Oslo in Norway, the senior lead on the study.

"The new model enables studies of the complex interactions between host cells, mucus production, and gut microbes in a system that closely mimics the situation in human patients," Dawson said.

Although localized inflammation and differences in the gut microbiome have been linked to the symptoms of ulcerative colitis and Crohn's disease -- the two forms of IBD -- the precise cause of these disorders is still unknown. Studies of IBD are typically performed using cell culture experiments or animal models, which don't mimic the precise conditions that occur in the gut of human patients. When using biopsied tissue, researchers rely on a device known as the Ussing chamber, which clamps the sample in place under static growth conditions -- crushing parts of the sample and keeping it viable for approximately eight hours. Instead of such static culture conditions, Dawson and her colleagues turned to a dual flow microfluidic chamber -- which removes wastes and supplies nutrients via continuous liquid streams -- and can keep tissues viable for prolonged periods of time.

To study biopsied intestinal samples, the research team engineered a microfluidic chamber where intact tissues can be inserted in a known orientation. Fluid flow on either side of the tissue mimicked the luminal and serosal surfaces of the gut within the body. Tissue samples were collected from patients who were undergoing biopsies after a diagnosis of IBD, and from patients suffering colon cancer whose tissues were unaffected by IBD-linked changes.

In the first 24 hours, tissues released large amounts of lactate dehydrogenase, an enzyme marker linked to cell death -- likely because cells were damaged during the surgery and setting up the device, Dawson explained. But after this initial spike, enzyme functions and microscopic analysis showed that the tissues remained alive and viable for up to 72 hours within the dual-flow device.

"You would expect some form of decay after removal from the human body," Dawson said. "But the tissue remains functional for a significant amount of time."

Nearly 85 percent of patient samples could be successfully used to create such IBD models. Using these biopsies to test different treatment plans could also help to quickly identify personalized plans to treat patients' disorders.

"The model is relatively easy to establish in any laboratory and can be applied to many kinds of tests, as it is more similar to the reality of the human body," Dawson added.

In future studies, the team plans to use the model to better understand how microbes, host factors and inflammatory markers interact to produce the hallmarks of inflammatory disease in the intestine.

"It's crucial to understand the gut bacteria and this interplay," said Dawson. "At the moment, there are no consistent patterns amongst people who have IBD and those who don't."
-end-
The article, "A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow," is authored by Amy Dawson, Charlotte Dyer, John Macife, John Greenman, John Davies, Laslo Karsai and Morten Jacobsen. The article appeared in the journal Biomicrofluidics November 1, 2016 (DOI: 10.1063/1.4964813) and can be accessed at http://scitation.aip.org/content/aip/journal/bmf/10/6/10.1063/1.4964813.

ABOUT THE JOURNAL

Biomicrofluidics publishes research highlighting fundamental physiochemical mechanisms associated with microfluidic and nanofluidic phenomena as well as novel microfluidic and nanofluidic techniques for diagnostic, medical, biological, pharmaceutical, environmental, and chemical applications. See http://bmf.aip.org.

American Institute of Physics

Related Inflammatory Bowel Disease Articles:

Inflammatory bowel disease: Scientists zoom in on genetic culprits
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease.
Social media help identify medication concerns of inflammatory bowel disease patients
Cedars-Sinai researchers analyzed thousands of social media posts to determine the biggest concerns patients with inflammatory bowel disease (IBD) have about their prescribed treatments.
New research suggests new ways to detect and monitor inflammatory bowel disease
A University of Manchester test on the mucus lining of the intestine, performed in mice, has found changes in bacteria that could lead to inflammatory bowel disease 12 weeks earlier than previously possible through looking at stool samples, leading to the possibility of earlier diagnosis and better management of the disease in humans.
Gut microbiome may predict response to biologic therapy for inflammatory bowel disease
Researchers from Massachusetts General Hospital and the Broad Institute of MIT and Harvard have identified differences in the composition and the function of the gut microbiome between patients for whom treatment with a monclonal antibody-based drug was effective in inducing remission of inflammatory bowel disease symptoms and those for whom it was not.
Study identifies a new test to predict severity of inflammatory bowel disease in children
The results from a Norwegian study show that a new genetic test for characterising intestinal microbiota may help to diagnose inflammatory bowel disease (IBD) in children and predict which children will develop the most extensive disease and need early, aggressive intervention.
What's the best way for patients with inflammatory bowel disease to address abdominal pain
When researchers analyzed published studies on how to treat recurrent abdominal pain among patients with inflammatory bowel disease, which includes Crohn's disease and ulcerative colitis, stress management appeared to be a promising strategy.
Researchers uncover key role for microRNA in inflammatory bowel disease
An international team of researchers has discovered that a microRNA produced by certain white blood cells can prevent excessive inflammation in the intestine.
Ingesting soy protein may ease severity of inflammatory bowel disease
A diet supplemented with soy protein may be an effective adjunct therapy for inflammatory bowel diseases, Penn State researchers reported after completing a study that included mice and cultured human colon cells.
Study identifies a genetic link to susceptibility and resistance to inflammatory bowel disease
Inflammatory bowel disease (IBD), characterized by chronic relapsing inflammation of the gut, is a common problem in the industrialized world.
Biologic treatments for inflammatory bowel disease help heal the intestine
Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ultimately require surgery.

Related Inflammatory Bowel Disease Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".